Helping to Bring Improved and Novel Therapies to the Right Patient Population Faster
Case study – Gene expression profiling to understand and combat drug resistance
Case study – Gene expression profiling to understand and combat drug resistance RNA sequencing [...]
Proposed new combination treatment strategy for pediatric ALL published in Nature Communication
Oncolines contributes to a proposed new combination treatment strategy for pediatric acute lymphoblastic leukemia published [...]
Oncolines News Flash
First presentation of novel mitotic checkpoint inhibitor BAL0891 data at ESMO TAT congress 2022 [...]
PREMIUM BENEFITS OF ONCOLINES BIOCHEMICAL ASSAY PLATFORMS: Protein Kinases, Drug-Target Interactions, Differentiation
Screening services to find compounds with the best structure activity relationship
Determination of kinetic and activity-based selectivity
Differentiation of compounds by binding on- and off-rates
Biochemical and cell-based profiling under one roof
Science driven technology platforms like ResidenceTimer™
Short turnaround times: gain access to your data in weeks, not months
